CognitMarket market news, portfolio research, and investor insights

Italian luxury group Armani is actively pursuing the sale of a 15% stake, as stipulated in founder Giorgio Armani's will. CEO Giuseppe Marsocci confirmed the company is open to involving multiple investors, with LVMH, L'Oreal, and EssilorLuxottica named as preferred buyers 🔗.

Key points:

• CEO Marsocci stated that it's "not written in stone" that only one investor will acquire the stake 🔗.
• The Financial Times reports meetings are scheduled with the three luxury giants to discuss a potential shared 15% holding 🔗.
• The transaction is expected to occur within 12-18 months of the founder's death, with price and details still under negotiation 🔗.

This strategic move could significantly impact the luxury sector and the involved public companies.

Citi analysts warn that Meta's Muse AI agent, by enabling easier comparison shopping, could pressure margins for retail electricity providers like NRG Energy (NYSE:NRG), Vistra (NYSE:VST), and Constellation Energy (NASDAQ:CEG) 🔗.

Key points:

• AI agents increase consumer price sensitivity and switching activity.
• Smaller providers face the greatest risk, while NRG is better positioned due to lower costs and scale.
• Increased competition could weaken margins in the short-to-medium term.
• Stronger operators may gain market share long-term as weaker competitors exit 🔗.

This highlights a new vector of AI disruption impacting traditional sectors.

Circle Internet Group (CRCL) stock fell 2.6% in extended trading after CFO Jeremy Fox-Geen and co-founder Sean Neville announced their departures 🔗. Fox-Geen, who oversaw a $1.2 billion IPO, will receive a $1.05 million severance package. While characterized as amicable, these executive transitions introduce short-term governance headwinds for the stablecoin provider as it navigates evolving digital asset regulations 🔗. Investors will monitor the company's executive search and operational continuity. #CRCL #Crypto #Fintech #ExecutiveChange

Humana Inc. (HUM) shares jumped 6% today after Barclays upgraded the health insurer to Overweight from Equal-Weight. The upgrade is driven by increased conviction in Humana's upcoming Medicare Star ratings, with Barclays raising the probability of a key contract (H5216, covering 2.4M lives) achieving bonus status to 75%. This contract is critical for Humana's 2028 EPS target, representing an estimated $1.5 billion of EBIT and $9 of EPS. The Medicare Star ratings release is expected around October 8th 🔗.

A federal appeals court upheld the Department of War's decision to remove AI developer Anthropic (ANTP) from its supply chain due to usage restrictions on its Claude AI model 🔗. This ruling highlights growing tensions between AI developers and government demands for unrestricted use, particularly in military applications.

Separately, Microsoft co-founder Bill Gates is advocating for strict federal AI regulation, warning of the technology's potential for mass casualties in the wrong hands 🔗. These developments signal an accelerating push for AI governance and could impact future AI development and deployment across sectors.

The AI infrastructure buildout continues to drive market activity, with several companies benefiting from significant deals and bullish analyst sentiment:

• Anthropic's $11.6B Computing Deal: European AI-linked stocks, including ASML, Infineon, and STMicroelectronics, rallied following Anthropic's massive computing deal, signaling sustained demand for AI hardware 🔗.
• Data Center Expansion: Cipher Digital (CIFR) surged 5.9% after extending its Barber Lake data center lease to 20 years, boosting contracted revenue to over $9 billion with a commitment from a leading AI lab 🔗. Atlas Energy Solutions (AESI) jumped 13% on new power equipment deals for AI data centers 🔗.
• AI Optical Growth: Mizuho initiated coverage on Tower Semiconductor (TSEM) with an Outperform rating and $300 price target, highlighting its leadership in silicon photonics chips crucial for AI data center connectivity 🔗.

This trend underscores the ongoing investment and expansion in the AI ecosystem, from chip manufacturing to data center power and infrastructure.

The AI infrastructure buildout is accelerating, with European AI-linked stocks rallying after Anthropic signed an $11.6 billion computing deal 🔗. This follows a prior $1.8 billion agreement, highlighting growing demand for AI software and computing capacity 🔗.

In the US, data center and power infrastructure providers are also seeing significant activity:

• Atlas Energy Solutions (AESI) jumped 13% premarket on new power equipment deals with a frontier AI lab for data center projects, including 283MW of incremental power generation 🔗.
• Cipher Digital (CIFR) rose 5.9% after extending its Barber Lake data center lease to 20 years, increasing total contracted revenue to over $9 billion, driven by a binding commitment from a leading AI lab 🔗.

This trend underscores the massive capital expenditure flowing into AI infrastructure, driving demand for chips, power, and data center capacity.

HSBC upgraded BP and TotalEnergies to 'Buy', raising price targets to 640p and €93 respectively, citing higher Brent crude, refining margin, and gas price forecasts. The bank increased 2026-28 EPS estimates across the sector by averages of 19-65% 🔗. Separately, UBS upgraded Glencore to 'Buy' with a 650p price target, driven by stronger Marketing division performance, rising commodity prices, and improved copper growth visibility. UBS raised Glencore's 2026-27 EBITDA estimates by 5-7% 🔗. These actions signal growing analyst confidence in the energy and commodities sector's earnings outlook.

Prime Medicine Inc (NASDAQ: PRME) shares gained over 12% in after-hours trading following FDA clearance of its Investigational New Drug (IND) application for PM647 🔗.

PM647 is an in vivo gene editing therapy targeting Alpha-1 Antitrypsin Deficiency (AATD), designed to correct the E342K mutation in the SERPINA1 gene. The planned Phase 1/2 clinical trial will evaluate safety, tolerability, and preliminary efficacy in adults with AATD 🔗.

This marks the company's second regulatory milestone, following clearance for PM577a, and aims to address both liver and lung manifestations of AATD, a condition with no approved curative treatment for its underlying genetic cause 🔗.

UBS has initiated coverage on five AI data center colocation stocks with 'Buy' ratings, citing rapid growth potential due to accelerating AI adoption and constrained computing capacity 🔗.

Key Highlights:

• Hut 8 Corp (HUT): Buy rating, $143 PT (45% upside), strong pipeline and value creation track record 🔗.
• Terawulf Inc (WULF): Buy rating, $24 PT (41% upside), differentiating ability to convert brownfield sites 🔗.
• Applied Digital Corp (APLD): Buy rating, $38 PT (35% upside), substantial 1.3 GW backlog 🔗.

Power access is noted as the primary limiting factor for scaling compute infrastructure. This analyst action signals strong conviction in the AI infrastructure sector's growth trajectory. 🔗